Healthy-Healthcare Lecture and Discussion Series - Part 2
The 2nd lecture and discussion from the Healthy-Healthcare series will be taken place on Friday 22nd of May. For more details, please see below.
Any of you would like to participate in this lecture, please contact the IJCC Secretariat at secretariat@ijcc.jp by Wednesday 20 May.
Healthy-Healthcare
A Lecture and Discussion Series - Jointly Presented by
Ireland Japan Chamber of Commerce
American Chamber of Commerce Japan
Temple University Japan - ICJS
Lecture 2: Friday May 22nd - 7.30pm - 9.30pm Temple University - Azabu Hall - Room 206
Title: "Patient Voice: The challenge of creating a framework of Patient Advocacy in Japan."
Outline: When faced with the major illness of cancer, heart disease, stroke or diabetes, how can patients and citizens get their voice heard on critical issues such as mixed quality of care or access to latest cutting-edge treatments? In Japan, patient advocacy groups are often said to be weak, isolated and unprofessional compared to international standards, perhaps due to a basic lack of infrastructure to support and a cultural reluctance to complain publicly. It is often left to non-profit organizations a) to incubate, educate and help institutionalize such motivated collections of concerned citizens. b) to bring doctors, bureaucrats and patients together, as equals, to discuss urgent shared problems and c) to educate young doctors on wider issues such as health policy down to patient interaction, to avoid cases of patients being told of terminal cancer on the telephone. In the age of the internet, information on treatment and drugs are widely available, patients are becoming more knowledgeable and more demanding. How can this trend be matched with the need to constrain costs in the overall system? Can patient voice can be a positive force to improve the overall healthcare standards, as surely all businesses must listen to their customers?
Speaker: Mr. Ryoji Noritake - (Health Policy Institute Japan - Commission on Citizens and Health)
